BioMarin Pharmaceutical Inc. (BMRN) ownership: Top institutional holder: BlackRock, Inc. ($1.12B). Insider activity: Net Seller (8 buys, 12 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 19818301.00 | $1.12B | 2026-03-31 |
| VANGUARD GROUP INC | 18127847.00 | $1.08B | 2025-12-31 |
| Dodge & Cox | 14561759.00 | $822.59M | 2026-03-31 |
| PRIMECAP MANAGEMENT CO/CA/ | 14194005.00 | $801.82M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8643164.00 | $488.25M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8298475.00 | $468.78M | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 7676541.00 | $429.35M | 2026-03-31 |
| STATE STREET CORP | 7295079.00 | $412.10M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-05-20 | |
| Sell | null | 2026-05-07 | |
| Buy | null | 2026-03-18 | |
| Buy | null | 2026-03-17 | |
| Buy | null | 2026-03-17 | |
| Buy | null | 2026-03-17 | |
| Buy | null | 2026-03-17 | |
| Buy | null | 2026-03-17 |
Back to BMRN overview · BMRN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.